| Serial Number | 88174433 |
| Word Mark | TCR² THERAPEUTICS |
| Filing Date | Tuesday, October 30, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 22, 2019 |
| Registration Number | 5892910 |
| Registration Date | Tuesday, October 22, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 30, 2019 |
| Description of Mark | The mark consists of four shaded oblongs centered above six shaded oblongs of the same size. The oblongs are to the left of the wording "TCR THERAPEUTICS" in stylized characters displayed on two lines with a "2" in stylized characters forming an exponent over "TCR". |
| Goods and Services | Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "TCR THERAPEUTICS" |
| Goods and Services | Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 14, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, July 24, 2019 |
| First Use In Commerce Date | Wednesday, July 24, 2019 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 14, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 30, 2016 |
| First Use In Commerce Date | Wednesday, November 30, 2016 |
| Party Name | TCR2 Therapeutics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | TCR2 Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | TCR2 Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Friday, November 2, 2018 | NEW APPLICATION ENTERED |
| Wednesday, November 14, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 15, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, January 25, 2019 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, January 29, 2019 | ASSIGNED TO LIE |
| Thursday, January 31, 2019 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Wednesday, February 6, 2019 | ASSIGNED TO EXAMINER |
| Monday, February 18, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, February 18, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, February 18, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 20, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 20, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 21, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 26, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 30, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 26, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 10, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 30, 2019 | PUBLISHED FOR OPPOSITION |
| Monday, September 9, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Monday, September 9, 2019 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 25, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, September 9, 2019 | SOU EXTENSION 1 FILED |
| Thursday, September 12, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, September 12, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, September 13, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 22, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 22, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Monday, September 9, 2019 | USE AMENDMENT FILED |
| Thursday, September 12, 2019 | SOU EXTENSION 1 GRANTED |
| Tuesday, September 17, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, September 18, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, August 20, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Wednesday, August 20, 2025 | WITHDRAWAL OF ATTORNEY GRANTED |